KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Return on Equity (2016 - 2026)

Medtronic (MDT) has disclosed Return on Equity for 12 consecutive years, with 0.09% as the latest value for Q1 2026.

  • Quarterly Return on Equity rose 1.0% to 0.09% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.09% through Jan 2026, up 1.0% year-over-year, with the annual reading at 0.1% for FY2025, 2.0% up from the prior year.
  • Return on Equity hit 0.09% in Q1 2026 for Medtronic, down from 0.1% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.1% in Q3 2022 to a low of 0.07% in Q3 2023.
  • Historically, Return on Equity has averaged 0.09% across 5 years, with a median of 0.09% in 2025.
  • Biggest five-year swings in Return on Equity: grew 4bps in 2022 and later decreased -3bps in 2023.
  • Year by year, Return on Equity stood at 0.08% in 2022, then fell by -3bps to 0.08% in 2023, then increased by 11bps to 0.09% in 2024, then increased by 11bps to 0.1% in 2025, then dropped by -4bps to 0.09% in 2026.
  • Business Quant data shows Return on Equity for MDT at 0.09% in Q1 2026, 0.1% in Q4 2025, and 0.1% in Q3 2025.